Altamira Therapeutics Ltd. Revenue From Contracts With Customers
Altamira Therapeutics Ltd. (CYTOF) reported Revenue From Contracts With Customers of CHF 379 for the 12-month period ending 2023-12-31, per its 20-F/A filed 2024-04-22.
Discontinued › Income Statement › Other Income
ifrs-full:RevenueFromContractsWithCustomers · last filed 2024-04-22
| Period end | Revenue From Contracts With Customers 12 month |
|---|---|
| 2023-12-31 | 379.00 CHF 20-F/A · filed 2024-04-22 |